Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. FDX
2. CBRS
3. KBH
4. USO
5. HON
6. HTZ
7. MRK
8. SPCX
9. TTWO
10. SPY

Go back to Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals (CPRX) Tops Q2 EPS by 28c

August 9, 2023 4:19 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q2 EPS of $0.53, $0.28 better than the analyst estimate of $0.25. Revenue for the quarter came in at $99.5 million versus the consensus estimate of $92.73 million.

GUIDANCE:

Catalyst Pharmaceuticals sees Q3 2023 revenue of $380-390 million.

For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.

... More